Coccygodynia. Sacrococcygeal disorders, not elsewhere classified
Conditions
Interventions
Intervention 1: In the intervention group 2cc Lidocaine 2% and 1cc of 40 mg teriamcinolon acetonide under sonography guide will be injected locally at the point of maximum tenderness in sacrococcygeal
In the intervention group 2cc Lidocaine 2% and 1cc of 40 mg teriamcinolon acetonide under sonography guide will be injected locally at the point of maximum tenderness in sacrococcygeal joint or tip of
In the intervention group 2cc Lidocaine 2% and 1cc of 40 mg teriamcinolon acetonide will be blind injected locally at the point of maximum tenderness in sacrococcygeal joint or tip of coccyx. And pati
Sponsors
Vice chancellor for research, Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 18 to 65 years; VAS scale equal to or more than 4 in any position of sitting, standing or supine lying; have not had coccyx injection or manipulation in past six months; the patients should not get pelvic floor physiotherapy during the treatment; maximum tenderness be in streptococcal joint or tip of coccyx. Exclusion criteria: the patients who do not refer to clinic for follow up or getting other treatments.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coccygeal pain. Timepoint: Before intervention, 1, 4 and 8 weeks after intervention. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient's quality of life. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: SF36 standard questionare. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdieh Asilian Mahabadi
Iran University of Medical Sciences
Outcome results
None listed